尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Smith Devin Whittemore, SVP et Conseiller Juridique Général. Officer active across 2 companies, notably Yumanity Therapeutics, INC.. Cumulatively, 5 reports have been recorded. Split: 1 buy · 2 sells. Total volume traded: €18k. Activity tracked since 1 December 2021. The latest transaction was filed on 23 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Devin Whittemore Smith is the SVP and General Counsel at YUMANITY THERAPEUTICS, INC. He oversees all legal matters for the company, including regulatory compliance and litigation. His role is crucial in ensuring the protection of the company's legal interests while supporting its strategic objectives. He works closely with management to navigate the complex legal landscape of the biopharmaceutical industry.